Powered By
Below is a listing of treatments, therapies, and surgeries for breast cancer. Click on one to read more information or connect with others currently using it.
Nerlynx (neratinib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.
These…
Overview
Ogivri is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat breast cancer in cases where tumors overexpress the HER2 protein. Ogivri is also known by its drug name,… read more
Ontruzant (trastuzumab-dttb) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.
…
Overview
Orserdu is approved by the U.S. Food and Drug Administration (FDA) for treating postmenopausal women and adult men with estrogen receptor-positive (ER-positive), HER2-negative, ESR1-mutated advanced, or…
Overview
Perjeta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and chemotherapy or anti-HER2 therapy… read more
Overview
Pertuzumab is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and chemotherapy or anti-HER2… read more
Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with…
read morePiqray (alpelisib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) in combination with fulvestrant to treat adults with HR-positive…
read moreOverview
Soltamox is approved by the U.S. Food and Drug Administration (FDA) for the treatment of estrogen receptor (ER)-positive metastatic breast cancer, as an adjuvant treatment for early-stage ER-positive breast…
Talzenna (talazoparib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with deleterious or suspected deleterious germline BRCA-mutated…
read moreOverview
Tamoxifen is a prescription drug first approved by the U.S. Food and Drug Administration (FDA) in 1977 to treat breast cancer. Tamoxifen was later also approved to prevent breast cancer. Tamoxifen is commonly… read more
Overview
Taxotere is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat locally advanced or metastatic breast cancer after chemotherapy hasn’t worked. Taxotere is also approved to treat… read more
Overview
Trastuzumab is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and one or more chemotherapy… read more
Trazimera (trastuzumab-qyyp) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.
…
Overview
Trodelvy is a combination prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with metastatic triple-negative breast cancer who have tried at least two other treatments.… read more
Overview
Truqap is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in combination with fulvestrant to treat some cases of hormone receptor (HR)-positive, human epidermal growth factor… read more
Tukysa (tucatinib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with human epidermal growth factor receptor-2 (HER2)-positive breast…
read moreTykerb (lapatinib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.
These…
Veppanu (vepdegestrant) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.
Veppanu is a type of…
Verzenio (abemaciclib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with breast cancer.
read moreOverview
Xeloda is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer. Xeloda may be prescribed either as monotherapy (on its own) in cases resistant to… read more
Overview
Zoladex is approved by the U.S. Food and Drug Administration (FDA) for the palliative treatment of advanced breast cancer in premenopausal and perimenopausal women, according to the prescribing information. This…
Become a member to get even more
Join
Your Privacy Choices
